nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—type 2 diabetes mellitus—obesity	0.323	0.583	CtDrD
Irbesartan—hypertension—obesity	0.231	0.417	CtDrD
Irbesartan—CYP2C8—Bupropion—obesity	0.0209	0.0856	CbGbCtD
Irbesartan—CYP1A2—Phentermine—obesity	0.019	0.078	CbGbCtD
Irbesartan—CYP1A2—Phenylpropanolamine—obesity	0.0181	0.0744	CbGbCtD
Irbesartan—CYP2C9—Phentermine—obesity	0.0171	0.0702	CbGbCtD
Irbesartan—CYP1A2—Bupropion—obesity	0.0161	0.0663	CbGbCtD
Irbesartan—CYP2D6—Phentermine—obesity	0.0156	0.0642	CbGbCtD
Irbesartan—CYP2C8—Cimetidine—obesity	0.0153	0.0628	CbGbCtD
Irbesartan—CYP2C9—Bupropion—obesity	0.0145	0.0597	CbGbCtD
Irbesartan—CYP2D6—Bupropion—obesity	0.0133	0.0546	CbGbCtD
Irbesartan—CYP3A4—Sibutramine—obesity	0.0131	0.0539	CbGbCtD
Irbesartan—CYP2D6—Methamphetamine—obesity	0.0125	0.0513	CbGbCtD
Irbesartan—CYP1A2—Cimetidine—obesity	0.0118	0.0486	CbGbCtD
Irbesartan—CYP2C9—Cimetidine—obesity	0.0107	0.0438	CbGbCtD
Irbesartan—CYP3A4—Benzphetamine—obesity	0.00995	0.0408	CbGbCtD
Irbesartan—CYP2D6—Cimetidine—obesity	0.00976	0.0401	CbGbCtD
Irbesartan—CYP3A4—Bupropion—obesity	0.00846	0.0347	CbGbCtD
Irbesartan—CYP3A4—Orlistat—obesity	0.00689	0.0283	CbGbCtD
Irbesartan—CYP3A4—Cimetidine—obesity	0.00621	0.0255	CbGbCtD
Irbesartan—CYP3A4—Topiramate—obesity	0.00406	0.0167	CbGbCtD
Irbesartan—JUN—hindbrain—obesity	0.00143	0.0688	CbGeAlD
Irbesartan—UGT1A3—digestive system—obesity	0.000982	0.0472	CbGeAlD
Irbesartan—JUN—islet of Langerhans—obesity	0.000925	0.0445	CbGeAlD
Irbesartan—JUN—respiratory system—obesity	0.000874	0.042	CbGeAlD
Irbesartan—UGT1A3—endocrine gland—obesity	0.000811	0.039	CbGeAlD
Irbesartan—EDNRA—adrenal cortex—obesity	0.000804	0.0386	CbGeAlD
Irbesartan—JUN—adrenal cortex—obesity	0.000733	0.0352	CbGeAlD
Irbesartan—UGT1A3—liver—obesity	0.000731	0.0351	CbGeAlD
Irbesartan—JUN—cardiovascular system—obesity	0.000669	0.0322	CbGeAlD
Irbesartan—EDNRA—pituitary gland—obesity	0.00065	0.0312	CbGeAlD
Irbesartan—EDNRA—adipose tissue—obesity	0.000647	0.0311	CbGeAlD
Irbesartan—JUN—pituitary gland—obesity	0.000593	0.0285	CbGeAlD
Irbesartan—JUN—adipose tissue—obesity	0.00059	0.0284	CbGeAlD
Irbesartan—EDNRA—adrenal gland—obesity	0.00058	0.0279	CbGeAlD
Irbesartan—JUN—digestive system—obesity	0.000556	0.0267	CbGeAlD
Irbesartan—AGTR1—adrenal cortex—obesity	0.000552	0.0265	CbGeAlD
Irbesartan—JUN—adrenal gland—obesity	0.000529	0.0254	CbGeAlD
Irbesartan—AGTR1—cardiovascular system—obesity	0.000504	0.0242	CbGeAlD
Irbesartan—JUN—endocrine gland—obesity	0.000459	0.0221	CbGeAlD
Irbesartan—AGTR1—pituitary gland—obesity	0.000446	0.0214	CbGeAlD
Irbesartan—AGTR1—adipose tissue—obesity	0.000444	0.0214	CbGeAlD
Irbesartan—JUN—liver—obesity	0.000414	0.0199	CbGeAlD
Irbesartan—AGTR1—adrenal gland—obesity	0.000399	0.0192	CbGeAlD
Irbesartan—CYP2D6—hindbrain—obesity	0.000389	0.0187	CbGeAlD
Irbesartan—AGTR1—endocrine gland—obesity	0.000346	0.0166	CbGeAlD
Irbesartan—CYP1A2—respiratory system—obesity	0.000334	0.016	CbGeAlD
Irbesartan—AGTR1—liver—obesity	0.000312	0.015	CbGeAlD
Irbesartan—PTGS1—respiratory system—obesity	0.000289	0.0139	CbGeAlD
Irbesartan—CYP2C9—cardiovascular system—obesity	0.000243	0.0117	CbGeAlD
Irbesartan—CYP2C8—pituitary gland—obesity	0.000242	0.0116	CbGeAlD
Irbesartan—PTGS1—cardiovascular system—obesity	0.000222	0.0106	CbGeAlD
Irbesartan—CYP1A2—digestive system—obesity	0.000212	0.0102	CbGeAlD
Irbesartan—CYP2C9—digestive system—obesity	0.000201	0.00968	CbGeAlD
Irbesartan—PTGS1—pituitary gland—obesity	0.000196	0.00943	CbGeAlD
Irbesartan—PTGS1—adipose tissue—obesity	0.000195	0.00939	CbGeAlD
Irbesartan—CYP2C8—endocrine gland—obesity	0.000187	0.00901	CbGeAlD
Irbesartan—PTGS1—digestive system—obesity	0.000184	0.00884	CbGeAlD
Irbesartan—CYP1A2—endocrine gland—obesity	0.000175	0.00843	CbGeAlD
Irbesartan—PTGS1—adrenal gland—obesity	0.000175	0.00842	CbGeAlD
Irbesartan—CYP2C8—liver—obesity	0.000169	0.00812	CbGeAlD
Irbesartan—CYP2C9—endocrine gland—obesity	0.000166	0.008	CbGeAlD
Irbesartan—CYP1A2—liver—obesity	0.000158	0.0076	CbGeAlD
Irbesartan—CYP3A4—digestive system—obesity	0.000154	0.00738	CbGeAlD
Irbesartan—PTGS1—endocrine gland—obesity	0.000152	0.0073	CbGeAlD
Irbesartan—CYP2D6—digestive system—obesity	0.000151	0.00727	CbGeAlD
Irbesartan—CYP2C9—liver—obesity	0.00015	0.00721	CbGeAlD
Irbesartan—CYP3A4—endocrine gland—obesity	0.000127	0.0061	CbGeAlD
Irbesartan—CYP2D6—endocrine gland—obesity	0.000125	0.006	CbGeAlD
Irbesartan—CYP3A4—liver—obesity	0.000114	0.0055	CbGeAlD
Irbesartan—CYP2D6—liver—obesity	0.000113	0.00541	CbGeAlD
Irbesartan—Losartan—ACE—obesity	0.000113	0.445	CrCbGaD
Irbesartan—Valsartan—ALB—obesity	9.44e-05	0.373	CrCbGaD
Irbesartan—Malaise—Sibutramine—obesity	9.13e-05	0.000953	CcSEcCtD
Irbesartan—Cough—Orlistat—obesity	9.13e-05	0.000953	CcSEcCtD
Irbesartan—Chills—Bupropion—obesity	9.1e-05	0.00095	CcSEcCtD
Irbesartan—Vertigo—Sibutramine—obesity	9.1e-05	0.00095	CcSEcCtD
Irbesartan—Syncope—Sibutramine—obesity	9.08e-05	0.000948	CcSEcCtD
Irbesartan—Leukopenia—Sibutramine—obesity	9.07e-05	0.000946	CcSEcCtD
Irbesartan—Arrhythmia—Bupropion—obesity	9.06e-05	0.000946	CcSEcCtD
Irbesartan—Face oedema—Topiramate—obesity	9.02e-05	0.000941	CcSEcCtD
Irbesartan—Myalgia—Orlistat—obesity	8.91e-05	0.00093	CcSEcCtD
Irbesartan—Chest pain—Orlistat—obesity	8.91e-05	0.00093	CcSEcCtD
Irbesartan—Loss of consciousness—Sibutramine—obesity	8.9e-05	0.000929	CcSEcCtD
Irbesartan—Anxiety—Orlistat—obesity	8.88e-05	0.000927	CcSEcCtD
Irbesartan—Mood swings—Topiramate—obesity	8.85e-05	0.000924	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	8.85e-05	0.000923	CcSEcCtD
Irbesartan—Cough—Sibutramine—obesity	8.84e-05	0.000922	CcSEcCtD
Irbesartan—Malnutrition—Bupropion—obesity	8.83e-05	0.000922	CcSEcCtD
Irbesartan—Discomfort—Orlistat—obesity	8.8e-05	0.000919	CcSEcCtD
Irbesartan—Hypertension—Sibutramine—obesity	8.74e-05	0.000913	CcSEcCtD
Irbesartan—Dry mouth—Orlistat—obesity	8.71e-05	0.000909	CcSEcCtD
Irbesartan—Flatulence—Bupropion—obesity	8.7e-05	0.000908	CcSEcCtD
Irbesartan—Tension—Bupropion—obesity	8.66e-05	0.000904	CcSEcCtD
Irbesartan—Dysgeusia—Bupropion—obesity	8.65e-05	0.000902	CcSEcCtD
Irbesartan—Liver function test abnormal—Topiramate—obesity	8.62e-05	0.0009	CcSEcCtD
Irbesartan—Arthralgia—Sibutramine—obesity	8.62e-05	0.0009	CcSEcCtD
Irbesartan—Chest pain—Sibutramine—obesity	8.62e-05	0.0009	CcSEcCtD
Irbesartan—Myalgia—Sibutramine—obesity	8.62e-05	0.0009	CcSEcCtD
Irbesartan—Anxiety—Sibutramine—obesity	8.59e-05	0.000897	CcSEcCtD
Irbesartan—Nervousness—Bupropion—obesity	8.57e-05	0.000895	CcSEcCtD
Irbesartan—Anaphylactic shock—Orlistat—obesity	8.54e-05	0.000891	CcSEcCtD
Irbesartan—Oedema—Orlistat—obesity	8.54e-05	0.000891	CcSEcCtD
Irbesartan—Orthostatic hypotension—Topiramate—obesity	8.53e-05	0.00089	CcSEcCtD
Irbesartan—Abdominal pain upper—Topiramate—obesity	8.53e-05	0.00089	CcSEcCtD
Irbesartan—Discomfort—Sibutramine—obesity	8.52e-05	0.000889	CcSEcCtD
Irbesartan—Hypokalaemia—Topiramate—obesity	8.5e-05	0.000887	CcSEcCtD
Irbesartan—Muscle spasms—Bupropion—obesity	8.49e-05	0.000886	CcSEcCtD
Irbesartan—Infection—Orlistat—obesity	8.48e-05	0.000886	CcSEcCtD
Irbesartan—Breast disorder—Topiramate—obesity	8.44e-05	0.000881	CcSEcCtD
Irbesartan—Dry mouth—Sibutramine—obesity	8.43e-05	0.00088	CcSEcCtD
Irbesartan—Toxic epidermal necrolysis—Topiramate—obesity	8.41e-05	0.000878	CcSEcCtD
Irbesartan—Nervous system disorder—Orlistat—obesity	8.38e-05	0.000874	CcSEcCtD
Irbesartan—Nasopharyngitis—Topiramate—obesity	8.35e-05	0.000872	CcSEcCtD
Irbesartan—Vision blurred—Bupropion—obesity	8.32e-05	0.000868	CcSEcCtD
Irbesartan—Skin disorder—Orlistat—obesity	8.3e-05	0.000866	CcSEcCtD
Irbesartan—Tremor—Bupropion—obesity	8.27e-05	0.000863	CcSEcCtD
Irbesartan—Anaphylactic shock—Sibutramine—obesity	8.27e-05	0.000863	CcSEcCtD
Irbesartan—Oedema—Sibutramine—obesity	8.27e-05	0.000863	CcSEcCtD
Irbesartan—Hyperhidrosis—Orlistat—obesity	8.26e-05	0.000862	CcSEcCtD
Irbesartan—Muscular weakness—Topiramate—obesity	8.24e-05	0.00086	CcSEcCtD
Irbesartan—Infection—Sibutramine—obesity	8.21e-05	0.000857	CcSEcCtD
Irbesartan—Ill-defined disorder—Bupropion—obesity	8.19e-05	0.000855	CcSEcCtD
Irbesartan—Anaemia—Bupropion—obesity	8.16e-05	0.000852	CcSEcCtD
Irbesartan—Shock—Sibutramine—obesity	8.13e-05	0.000849	CcSEcCtD
Irbesartan—Abdominal distension—Topiramate—obesity	8.13e-05	0.000848	CcSEcCtD
Irbesartan—Agitation—Bupropion—obesity	8.11e-05	0.000847	CcSEcCtD
Irbesartan—Thrombocytopenia—Sibutramine—obesity	8.09e-05	0.000845	CcSEcCtD
Irbesartan—Asthma—Topiramate—obesity	8.07e-05	0.000843	CcSEcCtD
Irbesartan—Dysphagia—Topiramate—obesity	8.07e-05	0.000843	CcSEcCtD
Irbesartan—Angioedema—Bupropion—obesity	8.07e-05	0.000842	CcSEcCtD
Irbesartan—Tachycardia—Sibutramine—obesity	8.07e-05	0.000842	CcSEcCtD
Irbesartan—Skin disorder—Sibutramine—obesity	8.03e-05	0.000838	CcSEcCtD
Irbesartan—Hyperhidrosis—Sibutramine—obesity	7.99e-05	0.000834	CcSEcCtD
Irbesartan—Malaise—Bupropion—obesity	7.96e-05	0.000831	CcSEcCtD
Irbesartan—Vertigo—Bupropion—obesity	7.93e-05	0.000828	CcSEcCtD
Irbesartan—Syncope—Bupropion—obesity	7.92e-05	0.000826	CcSEcCtD
Irbesartan—Pancreatitis—Topiramate—obesity	7.91e-05	0.000826	CcSEcCtD
Irbesartan—Leukopenia—Bupropion—obesity	7.9e-05	0.000825	CcSEcCtD
Irbesartan—Anorexia—Sibutramine—obesity	7.88e-05	0.000822	CcSEcCtD
Irbesartan—Angina pectoris—Topiramate—obesity	7.86e-05	0.000821	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Orlistat—obesity	7.78e-05	0.000812	CcSEcCtD
Irbesartan—Loss of consciousness—Bupropion—obesity	7.76e-05	0.00081	CcSEcCtD
Irbesartan—Hypotension—Sibutramine—obesity	7.72e-05	0.000806	CcSEcCtD
Irbesartan—Cough—Bupropion—obesity	7.7e-05	0.000804	CcSEcCtD
Irbesartan—Paraesthesia—Orlistat—obesity	7.67e-05	0.0008	CcSEcCtD
Irbesartan—Hypertension—Bupropion—obesity	7.62e-05	0.000796	CcSEcCtD
Irbesartan—Neutropenia—Topiramate—obesity	7.55e-05	0.000788	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Sibutramine—obesity	7.53e-05	0.000786	CcSEcCtD
Irbesartan—Dyspepsia—Orlistat—obesity	7.52e-05	0.000785	CcSEcCtD
Irbesartan—Arthralgia—Bupropion—obesity	7.52e-05	0.000785	CcSEcCtD
Irbesartan—Chest pain—Bupropion—obesity	7.52e-05	0.000785	CcSEcCtD
Irbesartan—Myalgia—Bupropion—obesity	7.52e-05	0.000785	CcSEcCtD
Irbesartan—Upper respiratory tract infection—Topiramate—obesity	7.5e-05	0.000783	CcSEcCtD
Irbesartan—Anxiety—Bupropion—obesity	7.49e-05	0.000782	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	7.46e-05	0.000779	CcSEcCtD
Irbesartan—Discomfort—Bupropion—obesity	7.43e-05	0.000775	CcSEcCtD
Irbesartan—Decreased appetite—Orlistat—obesity	7.42e-05	0.000775	CcSEcCtD
Irbesartan—Paraesthesia—Sibutramine—obesity	7.42e-05	0.000775	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Orlistat—obesity	7.37e-05	0.00077	CcSEcCtD
Irbesartan—Dyspnoea—Sibutramine—obesity	7.37e-05	0.000769	CcSEcCtD
Irbesartan—Photosensitivity reaction—Topiramate—obesity	7.37e-05	0.000769	CcSEcCtD
Irbesartan—Fatigue—Orlistat—obesity	7.36e-05	0.000769	CcSEcCtD
Irbesartan—Dry mouth—Bupropion—obesity	7.35e-05	0.000767	CcSEcCtD
Irbesartan—Somnolence—Sibutramine—obesity	7.35e-05	0.000767	CcSEcCtD
Irbesartan—Weight increased—Topiramate—obesity	7.35e-05	0.000767	CcSEcCtD
Irbesartan—Pain—Orlistat—obesity	7.3e-05	0.000762	CcSEcCtD
Irbesartan—Hyperglycaemia—Topiramate—obesity	7.28e-05	0.00076	CcSEcCtD
Irbesartan—Dyspepsia—Sibutramine—obesity	7.28e-05	0.000759	CcSEcCtD
Irbesartan—Pneumonia—Topiramate—obesity	7.24e-05	0.000756	CcSEcCtD
Irbesartan—Oedema—Bupropion—obesity	7.21e-05	0.000752	CcSEcCtD
Irbesartan—Anaphylactic shock—Bupropion—obesity	7.21e-05	0.000752	CcSEcCtD
Irbesartan—Decreased appetite—Sibutramine—obesity	7.18e-05	0.00075	CcSEcCtD
Irbesartan—Infection—Bupropion—obesity	7.16e-05	0.000747	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Sibutramine—obesity	7.14e-05	0.000745	CcSEcCtD
Irbesartan—Shock—Bupropion—obesity	7.09e-05	0.00074	CcSEcCtD
Irbesartan—Renal failure—Topiramate—obesity	7.08e-05	0.000739	CcSEcCtD
Irbesartan—Constipation—Sibutramine—obesity	7.07e-05	0.000738	CcSEcCtD
Irbesartan—Pain—Sibutramine—obesity	7.07e-05	0.000738	CcSEcCtD
Irbesartan—Nervous system disorder—Bupropion—obesity	7.07e-05	0.000738	CcSEcCtD
Irbesartan—Thrombocytopenia—Bupropion—obesity	7.05e-05	0.000736	CcSEcCtD
Irbesartan—Feeling abnormal—Orlistat—obesity	7.04e-05	0.000735	CcSEcCtD
Irbesartan—Tachycardia—Bupropion—obesity	7.03e-05	0.000734	CcSEcCtD
Irbesartan—Skin disorder—Bupropion—obesity	7e-05	0.000731	CcSEcCtD
Irbesartan—Conjunctivitis—Topiramate—obesity	7e-05	0.00073	CcSEcCtD
Irbesartan—Urinary tract infection—Topiramate—obesity	7e-05	0.00073	CcSEcCtD
Irbesartan—Gastrointestinal pain—Orlistat—obesity	6.98e-05	0.000729	CcSEcCtD
Irbesartan—Hyperhidrosis—Bupropion—obesity	6.97e-05	0.000727	CcSEcCtD
Irbesartan—Anorexia—Bupropion—obesity	6.87e-05	0.000717	CcSEcCtD
Irbesartan—Feeling abnormal—Sibutramine—obesity	6.81e-05	0.000711	CcSEcCtD
Irbesartan—Epistaxis—Topiramate—obesity	6.79e-05	0.000709	CcSEcCtD
Irbesartan—Urticaria—Orlistat—obesity	6.78e-05	0.000708	CcSEcCtD
Irbesartan—Gastrointestinal pain—Sibutramine—obesity	6.76e-05	0.000705	CcSEcCtD
Irbesartan—Abdominal pain—Orlistat—obesity	6.75e-05	0.000705	CcSEcCtD
Irbesartan—Body temperature increased—Orlistat—obesity	6.75e-05	0.000705	CcSEcCtD
Irbesartan—Hypotension—Bupropion—obesity	6.73e-05	0.000703	CcSEcCtD
Irbesartan—Agranulocytosis—Topiramate—obesity	6.72e-05	0.000701	CcSEcCtD
Irbesartan—Bradycardia—Topiramate—obesity	6.58e-05	0.000687	CcSEcCtD
Irbesartan—Urticaria—Sibutramine—obesity	6.57e-05	0.000685	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Bupropion—obesity	6.56e-05	0.000685	CcSEcCtD
Irbesartan—Abdominal pain—Sibutramine—obesity	6.53e-05	0.000682	CcSEcCtD
Irbesartan—Body temperature increased—Sibutramine—obesity	6.53e-05	0.000682	CcSEcCtD
Irbesartan—Rhinitis—Topiramate—obesity	6.48e-05	0.000676	CcSEcCtD
Irbesartan—Paraesthesia—Bupropion—obesity	6.47e-05	0.000675	CcSEcCtD
Irbesartan—Hepatitis—Topiramate—obesity	6.46e-05	0.000674	CcSEcCtD
Irbesartan—Hypoaesthesia—Topiramate—obesity	6.43e-05	0.000671	CcSEcCtD
Irbesartan—Dyspnoea—Bupropion—obesity	6.42e-05	0.000671	CcSEcCtD
Irbesartan—Pharyngitis—Topiramate—obesity	6.41e-05	0.000669	CcSEcCtD
Irbesartan—Somnolence—Bupropion—obesity	6.41e-05	0.000669	CcSEcCtD
Irbesartan—Urinary tract disorder—Topiramate—obesity	6.38e-05	0.000666	CcSEcCtD
Irbesartan—Oedema peripheral—Topiramate—obesity	6.37e-05	0.000664	CcSEcCtD
Irbesartan—Connective tissue disorder—Topiramate—obesity	6.35e-05	0.000663	CcSEcCtD
Irbesartan—Dyspepsia—Bupropion—obesity	6.34e-05	0.000662	CcSEcCtD
Irbesartan—Urethral disorder—Topiramate—obesity	6.33e-05	0.000661	CcSEcCtD
Irbesartan—Hypersensitivity—Orlistat—obesity	6.29e-05	0.000657	CcSEcCtD
Irbesartan—Decreased appetite—Bupropion—obesity	6.26e-05	0.000654	CcSEcCtD
Irbesartan—Visual impairment—Topiramate—obesity	6.23e-05	0.00065	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Bupropion—obesity	6.22e-05	0.000649	CcSEcCtD
Irbesartan—Fatigue—Bupropion—obesity	6.21e-05	0.000648	CcSEcCtD
Irbesartan—Constipation—Bupropion—obesity	6.16e-05	0.000643	CcSEcCtD
Irbesartan—Pain—Bupropion—obesity	6.16e-05	0.000643	CcSEcCtD
Irbesartan—Asthenia—Orlistat—obesity	6.13e-05	0.00064	CcSEcCtD
Irbesartan—Hypersensitivity—Sibutramine—obesity	6.09e-05	0.000636	CcSEcCtD
Irbesartan—Pruritus—Orlistat—obesity	6.04e-05	0.000631	CcSEcCtD
Irbesartan—Tinnitus—Topiramate—obesity	6.02e-05	0.000629	CcSEcCtD
Irbesartan—Cardiac disorder—Topiramate—obesity	6e-05	0.000626	CcSEcCtD
Irbesartan—Flushing—Topiramate—obesity	6e-05	0.000626	CcSEcCtD
Irbesartan—Feeling abnormal—Bupropion—obesity	5.94e-05	0.00062	CcSEcCtD
Irbesartan—Asthenia—Sibutramine—obesity	5.93e-05	0.000619	CcSEcCtD
Irbesartan—Gastrointestinal pain—Bupropion—obesity	5.89e-05	0.000615	CcSEcCtD
Irbesartan—Angiopathy—Topiramate—obesity	5.86e-05	0.000612	CcSEcCtD
Irbesartan—Pruritus—Sibutramine—obesity	5.85e-05	0.00061	CcSEcCtD
Irbesartan—Diarrhoea—Orlistat—obesity	5.84e-05	0.00061	CcSEcCtD
Irbesartan—Immune system disorder—Topiramate—obesity	5.84e-05	0.000609	CcSEcCtD
Irbesartan—Mediastinal disorder—Topiramate—obesity	5.82e-05	0.000608	CcSEcCtD
Irbesartan—Chills—Topiramate—obesity	5.8e-05	0.000605	CcSEcCtD
Irbesartan—Urticaria—Bupropion—obesity	5.72e-05	0.000597	CcSEcCtD
Irbesartan—Abdominal pain—Bupropion—obesity	5.7e-05	0.000595	CcSEcCtD
Irbesartan—Body temperature increased—Bupropion—obesity	5.7e-05	0.000595	CcSEcCtD
Irbesartan—Diarrhoea—Sibutramine—obesity	5.66e-05	0.00059	CcSEcCtD
Irbesartan—Dizziness—Orlistat—obesity	5.65e-05	0.000589	CcSEcCtD
Irbesartan—Erythema—Topiramate—obesity	5.62e-05	0.000587	CcSEcCtD
Irbesartan—Malnutrition—Topiramate—obesity	5.62e-05	0.000587	CcSEcCtD
Irbesartan—Flatulence—Topiramate—obesity	5.54e-05	0.000579	CcSEcCtD
Irbesartan—Tension—Topiramate—obesity	5.52e-05	0.000576	CcSEcCtD
Irbesartan—Dysgeusia—Topiramate—obesity	5.51e-05	0.000575	CcSEcCtD
Irbesartan—Dizziness—Sibutramine—obesity	5.47e-05	0.00057	CcSEcCtD
Irbesartan—Nervousness—Topiramate—obesity	5.46e-05	0.00057	CcSEcCtD
Irbesartan—Vomiting—Orlistat—obesity	5.43e-05	0.000567	CcSEcCtD
Irbesartan—Muscle spasms—Topiramate—obesity	5.41e-05	0.000564	CcSEcCtD
Irbesartan—Rash—Orlistat—obesity	5.38e-05	0.000562	CcSEcCtD
Irbesartan—Dermatitis—Orlistat—obesity	5.38e-05	0.000562	CcSEcCtD
Irbesartan—Headache—Orlistat—obesity	5.35e-05	0.000558	CcSEcCtD
Irbesartan—Hypersensitivity—Bupropion—obesity	5.31e-05	0.000554	CcSEcCtD
Irbesartan—Vision blurred—Topiramate—obesity	5.3e-05	0.000553	CcSEcCtD
Irbesartan—Tremor—Topiramate—obesity	5.27e-05	0.00055	CcSEcCtD
Irbesartan—Vomiting—Sibutramine—obesity	5.26e-05	0.000549	CcSEcCtD
Irbesartan—Ill-defined disorder—Topiramate—obesity	5.22e-05	0.000545	CcSEcCtD
Irbesartan—Rash—Sibutramine—obesity	5.21e-05	0.000544	CcSEcCtD
Irbesartan—Dermatitis—Sibutramine—obesity	5.21e-05	0.000543	CcSEcCtD
Irbesartan—Anaemia—Topiramate—obesity	5.2e-05	0.000543	CcSEcCtD
Irbesartan—Headache—Sibutramine—obesity	5.18e-05	0.00054	CcSEcCtD
Irbesartan—Asthenia—Bupropion—obesity	5.17e-05	0.00054	CcSEcCtD
Irbesartan—Agitation—Topiramate—obesity	5.17e-05	0.00054	CcSEcCtD
Irbesartan—Pruritus—Bupropion—obesity	5.1e-05	0.000532	CcSEcCtD
Irbesartan—Nausea—Orlistat—obesity	5.07e-05	0.00053	CcSEcCtD
Irbesartan—Malaise—Topiramate—obesity	5.07e-05	0.000529	CcSEcCtD
Irbesartan—Vertigo—Topiramate—obesity	5.05e-05	0.000527	CcSEcCtD
Irbesartan—Syncope—Topiramate—obesity	5.04e-05	0.000527	CcSEcCtD
Irbesartan—Leukopenia—Topiramate—obesity	5.03e-05	0.000526	CcSEcCtD
Irbesartan—Loss of consciousness—Topiramate—obesity	4.94e-05	0.000516	CcSEcCtD
Irbesartan—Diarrhoea—Bupropion—obesity	4.93e-05	0.000515	CcSEcCtD
Irbesartan—Nausea—Sibutramine—obesity	4.91e-05	0.000512	CcSEcCtD
Irbesartan—Cough—Topiramate—obesity	4.91e-05	0.000512	CcSEcCtD
Irbesartan—Hypertension—Topiramate—obesity	4.86e-05	0.000507	CcSEcCtD
Irbesartan—Myalgia—Topiramate—obesity	4.79e-05	0.0005	CcSEcCtD
Irbesartan—Chest pain—Topiramate—obesity	4.79e-05	0.0005	CcSEcCtD
Irbesartan—Arthralgia—Topiramate—obesity	4.79e-05	0.0005	CcSEcCtD
Irbesartan—Anxiety—Topiramate—obesity	4.77e-05	0.000498	CcSEcCtD
Irbesartan—Dizziness—Bupropion—obesity	4.76e-05	0.000497	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	4.76e-05	0.000496	CcSEcCtD
Irbesartan—Discomfort—Topiramate—obesity	4.73e-05	0.000494	CcSEcCtD
Irbesartan—Dry mouth—Topiramate—obesity	4.68e-05	0.000489	CcSEcCtD
Irbesartan—Losartan—ALB—obesity	4.61e-05	0.182	CrCbGaD
Irbesartan—Oedema—Topiramate—obesity	4.59e-05	0.000479	CcSEcCtD
Irbesartan—Vomiting—Bupropion—obesity	4.58e-05	0.000478	CcSEcCtD
Irbesartan—Infection—Topiramate—obesity	4.56e-05	0.000476	CcSEcCtD
Irbesartan—Rash—Bupropion—obesity	4.54e-05	0.000474	CcSEcCtD
Irbesartan—Dermatitis—Bupropion—obesity	4.54e-05	0.000474	CcSEcCtD
Irbesartan—Shock—Topiramate—obesity	4.52e-05	0.000471	CcSEcCtD
Irbesartan—Headache—Bupropion—obesity	4.51e-05	0.000471	CcSEcCtD
Irbesartan—Nervous system disorder—Topiramate—obesity	4.5e-05	0.00047	CcSEcCtD
Irbesartan—Thrombocytopenia—Topiramate—obesity	4.49e-05	0.000469	CcSEcCtD
Irbesartan—Tachycardia—Topiramate—obesity	4.48e-05	0.000468	CcSEcCtD
Irbesartan—Skin disorder—Topiramate—obesity	4.46e-05	0.000465	CcSEcCtD
Irbesartan—Hyperhidrosis—Topiramate—obesity	4.44e-05	0.000463	CcSEcCtD
Irbesartan—Anorexia—Topiramate—obesity	4.38e-05	0.000457	CcSEcCtD
Irbesartan—Hypotension—Topiramate—obesity	4.29e-05	0.000448	CcSEcCtD
Irbesartan—Nausea—Bupropion—obesity	4.28e-05	0.000447	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Topiramate—obesity	4.18e-05	0.000437	CcSEcCtD
Irbesartan—Paraesthesia—Topiramate—obesity	4.12e-05	0.00043	CcSEcCtD
Irbesartan—Dyspnoea—Topiramate—obesity	4.09e-05	0.000427	CcSEcCtD
Irbesartan—Somnolence—Topiramate—obesity	4.08e-05	0.000426	CcSEcCtD
Irbesartan—Dyspepsia—Topiramate—obesity	4.04e-05	0.000422	CcSEcCtD
Irbesartan—Decreased appetite—Topiramate—obesity	3.99e-05	0.000417	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Topiramate—obesity	3.96e-05	0.000414	CcSEcCtD
Irbesartan—Fatigue—Topiramate—obesity	3.96e-05	0.000413	CcSEcCtD
Irbesartan—Pain—Topiramate—obesity	3.93e-05	0.00041	CcSEcCtD
Irbesartan—Constipation—Topiramate—obesity	3.93e-05	0.00041	CcSEcCtD
Irbesartan—Feeling abnormal—Topiramate—obesity	3.78e-05	0.000395	CcSEcCtD
Irbesartan—Gastrointestinal pain—Topiramate—obesity	3.75e-05	0.000392	CcSEcCtD
Irbesartan—Urticaria—Topiramate—obesity	3.65e-05	0.000381	CcSEcCtD
Irbesartan—Abdominal pain—Topiramate—obesity	3.63e-05	0.000379	CcSEcCtD
Irbesartan—Body temperature increased—Topiramate—obesity	3.63e-05	0.000379	CcSEcCtD
Irbesartan—Hypersensitivity—Topiramate—obesity	3.38e-05	0.000353	CcSEcCtD
Irbesartan—Asthenia—Topiramate—obesity	3.29e-05	0.000344	CcSEcCtD
Irbesartan—Pruritus—Topiramate—obesity	3.25e-05	0.000339	CcSEcCtD
Irbesartan—Diarrhoea—Topiramate—obesity	3.14e-05	0.000328	CcSEcCtD
Irbesartan—Dizziness—Topiramate—obesity	3.04e-05	0.000317	CcSEcCtD
Irbesartan—Vomiting—Topiramate—obesity	2.92e-05	0.000305	CcSEcCtD
Irbesartan—Rash—Topiramate—obesity	2.89e-05	0.000302	CcSEcCtD
Irbesartan—Dermatitis—Topiramate—obesity	2.89e-05	0.000302	CcSEcCtD
Irbesartan—Headache—Topiramate—obesity	2.88e-05	0.0003	CcSEcCtD
Irbesartan—Nausea—Topiramate—obesity	2.73e-05	0.000285	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—PIK3CA—obesity	1.84e-06	2.15e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—POMC—obesity	1.84e-06	2.15e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—COMT—obesity	1.83e-06	2.15e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT3—obesity	1.83e-06	2.14e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—INS—obesity	1.83e-06	2.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPA—obesity	1.82e-06	2.13e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP2E1—obesity	1.82e-06	2.13e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CETP—obesity	1.81e-06	2.12e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GNB3—obesity	1.81e-06	2.12e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARGC1A—obesity	1.81e-06	2.12e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP2E1—obesity	1.8e-06	2.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HMOX1—obesity	1.8e-06	2.11e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NQO1—obesity	1.8e-06	2.1e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SDC1—obesity	1.79e-06	2.1e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPIN1—obesity	1.78e-06	2.09e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NQO1—obesity	1.78e-06	2.08e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CB—obesity	1.77e-06	2.07e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MTOR—obesity	1.77e-06	2.07e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKR1C3—obesity	1.76e-06	2.06e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GNAS—obesity	1.76e-06	2.06e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA5—obesity	1.75e-06	2.05e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.74e-06	2.04e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SCARB1—obesity	1.73e-06	2.03e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.73e-06	2.02e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOB—obesity	1.72e-06	2.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GCG—obesity	1.72e-06	2.02e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC2A4—obesity	1.72e-06	2.02e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.71e-06	2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GCG—obesity	1.71e-06	2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC2A4—obesity	1.71e-06	2e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MYC—obesity	1.7e-06	1.99e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYCS—obesity	1.7e-06	1.99e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—obesity	1.7e-06	1.99e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CD—obesity	1.69e-06	1.98e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	1.69e-06	1.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYCS—obesity	1.69e-06	1.97e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SREBF1—obesity	1.68e-06	1.97e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ALB—obesity	1.67e-06	1.96e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—PIK3CA—obesity	1.67e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GGT1—obesity	1.67e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GOT1—obesity	1.67e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC22A1—obesity	1.67e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CLOCK—obesity	1.67e-06	1.95e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GGT1—obesity	1.65e-06	1.94e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GOT1—obesity	1.65e-06	1.94e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—LPL—obesity	1.65e-06	1.93e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NCOA1—obesity	1.64e-06	1.92e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT2—obesity	1.64e-06	1.92e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—obesity	1.63e-06	1.91e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NCOA1—obesity	1.63e-06	1.91e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SULT2A1—obesity	1.62e-06	1.9e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GLP1R—obesity	1.62e-06	1.9e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—STK11—obesity	1.62e-06	1.9e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CYP19A1—obesity	1.62e-06	1.9e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.61e-06	1.89e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GPX1—obesity	1.61e-06	1.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CYP19A1—obesity	1.61e-06	1.88e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—STK11—obesity	1.61e-06	1.88e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FASN—obesity	1.6e-06	1.88e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3R1—obesity	1.6e-06	1.87e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—NOS3—obesity	1.6e-06	1.87e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PIK3CA—obesity	1.6e-06	1.87e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DPYD—obesity	1.6e-06	1.87e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BCHE—obesity	1.6e-06	1.87e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD36—obesity	1.56e-06	1.83e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP2E1—obesity	1.54e-06	1.8e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PRKAR2B—obesity	1.54e-06	1.8e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—obesity	1.54e-06	1.8e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DCN—obesity	1.53e-06	1.79e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NQO1—obesity	1.52e-06	1.78e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—COMT—obesity	1.51e-06	1.76e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—AKT1—obesity	1.5e-06	1.76e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK8—obesity	1.5e-06	1.75e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—COMT—obesity	1.49e-06	1.75e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.49e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CPT1A—obesity	1.49e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GNB3—obesity	1.48e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARGC1A—obesity	1.48e-06	1.74e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—MTHFR—obesity	1.48e-06	1.73e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HMOX1—obesity	1.48e-06	1.73e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—obesity	1.48e-06	1.73e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CB—obesity	1.48e-06	1.73e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.48e-06	1.73e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARGC1A—obesity	1.47e-06	1.72e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GNB3—obesity	1.47e-06	1.72e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HMOX1—obesity	1.46e-06	1.71e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—obesity	1.46e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GCG—obesity	1.46e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC2A4—obesity	1.46e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NAMPT—obesity	1.46e-06	1.71e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARA—obesity	1.45e-06	1.7e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LIPC—obesity	1.45e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCK—obesity	1.45e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GNAS—obesity	1.45e-06	1.69e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—PIK3CA—obesity	1.44e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYCS—obesity	1.44e-06	1.69e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOC3—obesity	1.44e-06	1.68e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GNAS—obesity	1.43e-06	1.68e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOB—obesity	1.42e-06	1.66e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GGT1—obesity	1.41e-06	1.65e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GOT1—obesity	1.41e-06	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AGT—obesity	1.41e-06	1.65e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOB—obesity	1.4e-06	1.64e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CETP—obesity	1.4e-06	1.64e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NCOA1—obesity	1.39e-06	1.63e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SDC1—obesity	1.38e-06	1.62e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOE—obesity	1.38e-06	1.62e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—STK11—obesity	1.37e-06	1.61e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CYP19A1—obesity	1.37e-06	1.61e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT3—obesity	1.37e-06	1.6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CAV1—obesity	1.37e-06	1.6e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—APOA1—obesity	1.36e-06	1.6e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—AKT1—obesity	1.36e-06	1.6e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKR1C3—obesity	1.36e-06	1.59e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—LPL—obesity	1.35e-06	1.58e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—LPL—obesity	1.34e-06	1.57e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SCARB1—obesity	1.34e-06	1.57e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GPX1—obesity	1.32e-06	1.54e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GPX1—obesity	1.31e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.31e-06	1.53e-05	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—AKT1—obesity	1.31e-06	1.53e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SREBF1—obesity	1.3e-06	1.52e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD36—obesity	1.28e-06	1.5e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—obesity	1.28e-06	1.5e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—COMT—obesity	1.28e-06	1.49e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD36—obesity	1.27e-06	1.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MYC—obesity	1.27e-06	1.49e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—obesity	1.27e-06	1.48e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT2—obesity	1.26e-06	1.48e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARGC1A—obesity	1.26e-06	1.47e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GNB3—obesity	1.26e-06	1.47e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HMOX1—obesity	1.25e-06	1.47e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CG—obesity	1.25e-06	1.46e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FASN—obesity	1.24e-06	1.45e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BCHE—obesity	1.23e-06	1.44e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GNAS—obesity	1.22e-06	1.43e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—MTHFR—obesity	1.22e-06	1.42e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—MTHFR—obesity	1.21e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARG—obesity	1.2e-06	1.41e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOB—obesity	1.2e-06	1.4e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARA—obesity	1.19e-06	1.4e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP2E1—obesity	1.19e-06	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—POMC—obesity	1.19e-06	1.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARA—obesity	1.18e-06	1.39e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—AKT1—obesity	1.18e-06	1.38e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—INS—obesity	1.18e-06	1.38e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NQO1—obesity	1.17e-06	1.37e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AGT—obesity	1.16e-06	1.35e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AGT—obesity	1.15e-06	1.34e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—LPL—obesity	1.14e-06	1.34e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOE—obesity	1.13e-06	1.33e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC2A4—obesity	1.13e-06	1.32e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GCG—obesity	1.13e-06	1.32e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOE—obesity	1.12e-06	1.31e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CAV1—obesity	1.12e-06	1.31e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—APOA1—obesity	1.12e-06	1.31e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GPX1—obesity	1.12e-06	1.31e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CAV1—obesity	1.11e-06	1.3e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYCS—obesity	1.11e-06	1.3e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—APOA1—obesity	1.11e-06	1.3e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CD—obesity	1.09e-06	1.28e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GOT1—obesity	1.09e-06	1.28e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GGT1—obesity	1.09e-06	1.28e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD36—obesity	1.09e-06	1.27e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ALB—obesity	1.08e-06	1.27e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—PIK3CA—obesity	1.08e-06	1.26e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NCOA1—obesity	1.07e-06	1.26e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.06e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—STK11—obesity	1.06e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CYP19A1—obesity	1.06e-06	1.24e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—NOS3—obesity	1.03e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3R1—obesity	1.03e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—MTHFR—obesity	1.03e-06	1.21e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CG—obesity	1.02e-06	1.2e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CG—obesity	1.01e-06	1.19e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARA—obesity	1.01e-06	1.18e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARG—obesity	9.87e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—COMT—obesity	9.84e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AGT—obesity	9.79e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARG—obesity	9.78e-07	1.15e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—POMC—obesity	9.73e-07	1.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARGC1A—obesity	9.71e-07	1.14e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GNB3—obesity	9.71e-07	1.14e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—INS—obesity	9.68e-07	1.13e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HMOX1—obesity	9.66e-07	1.13e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—POMC—obesity	9.65e-07	1.13e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOE—obesity	9.6e-07	1.12e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—INS—obesity	9.59e-07	1.12e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—obesity	9.55e-07	1.12e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CB—obesity	9.54e-07	1.12e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CAV1—obesity	9.51e-07	1.11e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—APOA1—obesity	9.49e-07	1.11e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—obesity	9.46e-07	1.11e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GNAS—obesity	9.45e-07	1.11e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOB—obesity	9.25e-07	1.08e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.08e-07	1.06e-05	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PIK3CA—obesity	9.01e-07	1.05e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CD—obesity	8.99e-07	1.05e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CD—obesity	8.91e-07	1.04e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ALB—obesity	8.87e-07	1.04e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—LPL—obesity	8.84e-07	1.03e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—AKT1—obesity	8.81e-07	1.03e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ALB—obesity	8.8e-07	1.03e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CG—obesity	8.66e-07	1.01e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GPX1—obesity	8.62e-07	1.01e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—NOS3—obesity	8.49e-07	9.93e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3R1—obesity	8.49e-07	9.93e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3R1—obesity	8.41e-07	9.85e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—NOS3—obesity	8.41e-07	9.85e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD36—obesity	8.4e-07	9.83e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARG—obesity	8.36e-07	9.78e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—POMC—obesity	8.24e-07	9.65e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—INS—obesity	8.2e-07	9.6e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—MTHFR—obesity	7.96e-07	9.31e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CB—obesity	7.83e-07	9.17e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARA—obesity	7.81e-07	9.14e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CB—obesity	7.77e-07	9.09e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—obesity	7.76e-07	9.09e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—obesity	7.7e-07	9.01e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CD—obesity	7.61e-07	8.91e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AGT—obesity	7.56e-07	8.85e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ALB—obesity	7.52e-07	8.8e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOE—obesity	7.41e-07	8.67e-06	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—AKT1—obesity	7.36e-07	8.61e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CAV1—obesity	7.34e-07	8.59e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—APOA1—obesity	7.32e-07	8.57e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3R1—obesity	7.19e-07	8.42e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—NOS3—obesity	7.19e-07	8.42e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CG—obesity	6.68e-07	7.82e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CB—obesity	6.64e-07	7.77e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—obesity	6.58e-07	7.7e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARG—obesity	6.45e-07	7.55e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—POMC—obesity	6.36e-07	7.45e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—INS—obesity	6.33e-07	7.41e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CD—obesity	5.88e-07	6.88e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PIK3CA—obesity	5.82e-07	6.81e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ALB—obesity	5.8e-07	6.79e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—NOS3—obesity	5.55e-07	6.49e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3R1—obesity	5.55e-07	6.49e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CB—obesity	5.12e-07	6e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—obesity	5.08e-07	5.94e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PIK3CA—obesity	4.78e-07	5.59e-06	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—AKT1—obesity	4.75e-07	5.56e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PIK3CA—obesity	4.73e-07	5.54e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PIK3CA—obesity	4.05e-07	4.74e-06	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—AKT1—obesity	3.9e-07	4.57e-06	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—AKT1—obesity	3.87e-07	4.53e-06	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—AKT1—obesity	3.31e-07	3.87e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PIK3CA—obesity	3.12e-07	3.65e-06	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—AKT1—obesity	2.55e-07	2.99e-06	CbGpPWpGaD
